High levels of IFN-γ are associated with improved survival in breast cancer patients due to its role in orchestrating effective antitumor immunity, though it can also exhibit protumorigenic roles by promoting immune escape mechanisms [6,9]. Here, IFNG is linked to breast carcinoma.